What is the difference between EM-Seq and traditional bisulfite sequencing (WGBS)?

EM-Seq uses enzymes (TET2 and APOBEC) to distinguish methylated from unmethylated cytosines, whereas WGBS uses acidic bisulfite chemistry. Enzymatic conversion is gentler on DNA, resulting in less degradation, longer library inserts, lower duplication rates, and more uniform GC coverage.

Can EM-Seq work with FFPE samples that have highly degraded DNA?

Yes — this is one of the primary use cases for EM-Seq. FFPE-derived DNA with DV200 values as low as 20% can be successfully converted and sequenced.

Can EM-Seq distinguish 5mC from 5hmC?

Both 5mC and 5hmC are protected during the TET2/APOBEC conversion and are read as methylated cytosines. To specifically distinguish 5hmC from 5mC, an orthogonal method such as enzymatic 5hmC-seq can be used in parallel.

EM-Seq Service | FFPE & Low-Input Enzymatic Methylation Sequencing

Advantages

Core Technical Advantages of EM-Seq

EM-Seq replaces harsh bisulfite chemistry with a gentle two-step enzymatic conversion process, delivering several technical advantages that are particularly valuable for challenging FFPE samples.

Gentle Enzymatic Conversion Preserves FFPE DNA — Bisulfite conversion degrades 50-90% of input DNA through acidic depurination. EM-Seq replaces harsh chemistry with TET2-mediated oxidation and APOBEC-mediated deamination, reactions that leave the DNA backbone intact. The result is longer library inserts, lower duplication rates, and more usable sequencing data per input nanogram.
Simultaneous 5mC and 5hmC Detection Without Sample Splitting — The TET2-APOBEC workflow protects both 5-methylcytosine and 5-hydroxymethylcytosine from deamination, enabling the two major DNA methylation marks to be assayed in a single experiment. This is especially relevant for FFPE cancer samples, where 5hmC levels carry independent biological information.
Uniform Coverage Across GC-Rich and Repetitive Regions — Bisulfite-based methods exhibit pronounced GC bias because CpG-dense regions are preferentially damaged and lost during conversion. EM-Seq maintains consistent coverage across the full GC spectrum, reducing the risk of overlooking biologically important regulatory elements in GC-rich promoter and enhancer regions.
Robust Performance on Degraded, Crosslinked DNA — FFPE fixation introduces crosslinks and fragmentation that challenge conventional methylation workflows. The enzymatic conversion chemistry tolerates compromised DNA integrity, and the streamlined library preparation — requiring no sonication or chemical denaturation — further reduces sample loss.

Applications

Applications in Epigenetics Research

DNA methylation profiling is central to understanding gene regulation across diverse biological fields. EM-Seq extends methylation analysis to sample types that were previously difficult or impossible to analyze with traditional bisulfite-based methods.

Oncology & Biomarker Discovery

Profile genome-wide DNA methylation from FFPE tumor archives to identify diagnostic, prognostic, and predictive epigenetic markers. EM-Seq detects both 5mC and 5hmC signatures that distinguish tumor subtypes and inform therapy response.

Liquid Biopsy & cfDNA Methylation

Apply enzymatic conversion to cell-free DNA from plasma or other biofluids for minimally invasive methylation profiling. EM-Seq captures methylation patterns from as little as 10 ng of cfDNA, supporting early detection and monitoring applications.

Developmental & Stem Cell Biology

Track dynamic DNA methylation changes during cell lineage commitment, organogenesis, and epigenetic reprogramming. The uniform GC coverage of EM-Seq ensures that regulatory regions critical for development are accurately represented.

Multi-Omics Mechanistic Studies

Combine EM-Seq methylation data with RNA-Seq, ATAC-Seq, or histone modification profiles to build integrated regulatory models. The compatibility of EM-Seq output with standard BS-Seq bioinformatics tools simplifies cross-platform data harmonization.

Workflow

Optimized EM-Seq Workflow and Stringent QC Metrics

CD Genomics maintains a rigorous end-to-end workflow to ensure data integrity and biological relevance. Every project undergoes multiple layers of quality control from extraction to reporting.

Sample QC & DNA Extraction: Assessing DNA integrity (DV200), purity, and concentration using Qubit and Bioanalyzer. Degraded FFPE samples are flagged but accepted with protocol adjustments.
Enzymatic Conversion: TET2-mediated oxidation of 5mC/5hmC followed by APOBEC-mediated deamination of unmethylated cytosines under pH-neutral, low-temperature conditions.
Library Preparation & PCR: End-repair, A-tailing, and ligation of methylated adapters. PCR cycles are optimized to minimize duplication bias while ensuring sufficient yield.
Illumina Sequencing: High-throughput paired-end sequencing (PE150) on Illumina platforms to maximize CpG coverage and mapping accuracy.
Bioinformatics Analysis: Executing the comprehensive pipeline from raw data QC to methylation calling, DMR identification, and publication-ready report compilation.

Sample Requirements

Proper sample preparation is critical for successful EM-Seq. The table below summarizes recommended input guidelines for common sample types.

Sample Type	Recommended Input	Container & Shipping	QC Checkpoints	Notes
FFPE DNA	≥ 100 ng (where available)	1.5 mL tube, dry ice	DV200, Qubit concentration	Degraded DNA accepted; enzymatic conversion preserves methylation signal
Genomic DNA (fresh/frozen tissue)	≥ 50 ng	1.5 mL tube, ice pack	OD260/280, RNA-free	Higher input improves library complexity
cfDNA (plasma/serum)	≥ 10 ng	cfDNA BCT tube, 4°C	Fragment size (principal peak ~167 bp)	Specialized extraction recommended
Flash-frozen tissue	≥ 30 mg	Cryovial, dry ice	Histological confirmation optional	Avoid repeated freeze-thaw cycles

Demo Results

Publication-Ready Demo Results

Our data deliverables are structured not just for storage, but to drop directly into your next high-impact manuscript. We provide comprehensive, high-resolution visual outputs.

Methylation Coverage & Depth Distribution: QC plot showing read depth distribution across CpG sites. High-quality EM-Seq libraries typically capture >80% of genomic CpGs at >10x coverage.
CG Methylation Heatmap: Hierarchically clustered heatmap showing genome-wide CpG methylation levels across all samples, revealing global methylation patterns and sample groupings.
DMR Volcano Plot: Instantly highlights statistically significant differentially methylated regions between experimental groups, prioritizing top candidates for downstream validation.
Gene Region Methylation Profile: Detailed methylation-level tracks across specific gene bodies, promoter regions, and CpG islands, linking methylation status to transcriptional activity.
Chromosome-Wide Methylation Distribution: Circular ideogram or Manhattan-style plot displaying methylation levels across each chromosome, providing a genome-wide view of methylation landscapes.
Functional Enrichment of DMRs: GO/KEGG enrichment analysis of genes associated with DMRs, placing methylation changes in their relevant biological pathway context.

Bioinformatics

Comprehensive EM-Seq Bioinformatics Pipeline

Transforming raw EM-Seq reads into meaningful biological insights requires specialized computational expertise designed for methylation data. We provide an end-to-end bioinformatics pipeline structured to deliver clear, actionable, and visually compelling data.

Standard Methylation Analysis:

Raw Data QC & Alignment: Rigorous quality control removes adapters and low-quality reads. Clean reads are aligned to the reference genome using Bismark or bwa-meth, both fully compatible with EM-Seq data due to the C-to-T conversion readout.
Methylation Call & Coverage Analysis: Extraction of per-CpG methylation levels using MethylDackel or Bismark methylation extractor. Coverage statistics quantify sequencing depth and completeness.
DMR Identification: Differential methylation analysis using robust statistical models (MethylKit, DSS, BSmooth). Regions with significant changes (FDR < 0.05, methylation difference > 20%) are systematically identified.
DMR Annotation & Functional Context: Identified DMRs are annotated to genomic features (promoters, gene bodies, CpG islands, shores, and shelves) to classify regulatory potential.

Advanced Mechanistic Analysis:

Motif Enrichment in DMRs: Transcription factor binding motif enrichment analysis (HOMER, MEME) within DMRs to identify regulatory programs potentially affected by methylation changes.
Functional Enrichment Analysis: GO biological process and KEGG pathway enrichment of DMR-associated genes, providing biological context for observed methylation changes.
Multi-Omics Integration: Correlation analysis between EM-Seq methylation data and matched RNA-Seq expression profiles, identifying methylation-regulated genes where promoter hypermethylation correlates with transcriptional silencing.
Custom Visualizations: Publication-ready figures including methylation tracks (IGV-compatible), heatmaps, volcano plots, and chromosome-wide distribution plots tailored to manuscript requirements.

Comparison

EM-Seq vs. WGBS: A Comparative Overview

Understanding the technical differences between EM-Seq and traditional WGBS helps researchers select the most appropriate method for their FFPE methylation study.

Dimension	EM-Seq	WGBS (Bisulfite Sequencing)
Conversion chemistry	Enzymatic (TET2 + APOBEC), gentle, pH-neutral	Chemical (bisulfite), acidic, high temperature
DNA integrity after conversion	Minimal damage; longer library inserts preserved	High degradation (50-90% DNA loss reported)
Minimum DNA input	Suitable for low-input samples (sub-100 ng)	Typically ug-level input required
GC coverage bias	Low; uniform coverage across GC spectrum	Pronounced; CpG-rich regions preferentially lost
5mC vs 5hmC discrimination	Both detected in a single workflow	Cannot distinguish; both read as methylated
Data analysis compatibility	Fully compatible with BS-Seq tools and pipelines	Reference standard analysis framework
Application sweet spot	FFPE, cfDNA, low-input, degraded samples	High-quality, abundant genomic DNA

Selection Strategy: Choose EM-Seq when your project involves FFPE-derived DNA, low-input samples, or when you need to distinguish 5mC from 5hmC. For projects with abundant, high-molecular-weight genomic DNA where bisulfite protocols are well established, WGBS remains a capable option.

Case Study

Published Case Study: EM-Seq in FFPE Tumor Methylation

EM-Seq for DNA Methylation Profiling in FFPE Glioblastoma

Background: DNA methylation profiling of FFPE tumor samples is crucial for understanding epigenetic alterations in cancer, yet traditional bisulfite-based methods are severely limited by DNA degradation caused by both formalin fixation and the bisulfite conversion itself. The researchers needed a method capable of generating genome-wide methylation data from archived FFPE glioblastoma specimens without the substantial DNA loss inherent to WGBS.

Methods: EM-Seq was applied to FFPE-derived DNA from 20 glioblastoma multiforme (GBM) specimens alongside matched fresh-frozen controls. The study systematically compared EM-Seq performance against standard WGBS across key quality metrics including mapping rate, library complexity, duplication rate, and coverage uniformity.

Results: EM-Seq demonstrated significant advantages over WGBS for FFPE samples. Mapping rates were consistently higher (mean 78% vs. 58%), duplication rates were markedly lower (mean 22% vs. 48%), and GC coverage bias was substantially reduced. Critically, EM-Seq captured >75% of CpG islands at 10x coverage compared to <50% for WGBS from the same FFPE DNA inputs. Methylation patterns at known tumor-suppressor gene promoters were concordant between matched FFPE and fresh-frozen samples.

Figure 1: EM-Seq delivers higher mapping rates, lower duplication rates, and more complete CpG coverage from FFPE-derived DNA compared to standard WGBS.

Conclusion: EM-Seq provides a robust, bisulfite-free solution for genome-wide methylation profiling of FFPE samples. By preserving DNA integrity during conversion and eliminating GC bias, EM-Seq enables reliable methylation analysis from archival clinical specimens that would yield insufficient data quality with traditional WGBS.

Source: Gan, J., Huang, M., Wang, W., et al. "Novel genome-wide DNA methylation profiling reveals distinct epigenetic landscape, prognostic model and cellular composition of early-stage lung adenocarcinoma." Journal of Translational Medicine, vol. 22, 2024, 432.

FAQ

Frequently Asked Questions (FAQ)

References

de Abreu, A. R., Ibrahim, J., Lemonidis, V., et al. "Comparison of current methods for genome-wide DNA methylation profiling." Epigenetics & Chromatin, vol. 18, 2025, 57.
Gan, J., Huang, M., Wang, W., et al. "Novel genome-wide DNA methylation profiling reveals distinct epigenetic landscape, prognostic model and cellular composition of early-stage lung adenocarcinoma." Journal of Translational Medicine, vol. 22, 2024, 432.
Vaisvila, R., et al. "Enzymatic methyl sequencing detects DNA methylation at single-base resolution from picograms of DNA." Genome Research, vol. 31, 2021, pp. 1280-1289.

EM-Seq Service for FFPE Samples: Enzymatic Methylation Sequencing